Trade Summary

1 week ago, Cacace Angela M, serving as Chief Scientific Officer at Arvinas, Inc. (ARVN), sold 4,592 shares at $11.89 per share, for a total transaction value of $54,599.00. Following this transaction, Cacace Angela M now holds 151,232 shares of ARVN.

This sale represents a 3.00% decrease in Cacace Angela M's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, February 13, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 5 days after the trade was made.

Arvinas, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.